Ansell's Malaysian glove facility awaits FDA reinspection to confirm GMP compliance.
This article was originally published in The Gray Sheet
ANSELL'S MALAYSIAN GLOVE FACILITY AWAITING FDA REINSPECTION following the company's steps to correct good manufacturing practices deficiencies identified by FDA. Ansell-Perry, which owns the facility and is a subsidiary of Ansell Healthcare, says it is working with the agency to set a date for reinspection, which is needed to confirm the facility's GMP compliance. The facility's latex surgical and exam gloves have been on import detention since November 3, 1995 due to GMP violations.
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.